Immunosuppressive agents and CMV risk in the VICTOR study.
Avery
R K
RK
Kaplan
B
B
D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D015774:Ganciclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016377:Organ Transplantation / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D000077562:Valganciclovir
D007166:Immunosuppressive Agents; D000077562:Valganciclovir; D015774:Ganciclovir